Healthcare Ebitda from 2010 to 2024

HCG Stock   473.05  4.75  1.01%   
Healthcare Global's EBITDA is increasing over the years with slightly volatile fluctuation. Overall, EBITDA is expected to go to about 3.7 B this year. During the period from 2010 to 2024 Healthcare Global EBITDA annual values regression line had geometric mean of  1,099,529,574 and mean square error of 464145.5 T. View All Fundamentals
 
EBITDA  
First Reported
2014-06-30
Previous Quarter
997.2 M
Current Value
1.1 B
Quarterly Volatility
274.4 M
 
Yuan Drop
 
Covid
Check Healthcare Global financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthcare Global's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 686 M or Selling General Administrative of 272.6 M, as well as many indicators such as . Healthcare financial statements analysis is a perfect complement when working with Healthcare Global Valuation or Volatility modules.
  
This module can also supplement various Healthcare Global Technical models . Check out the analysis of Healthcare Global Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Healthcare Stock

Healthcare Global financial ratios help investors to determine whether Healthcare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthcare with respect to the benefits of owning Healthcare Global security.